Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7Ilaria Lamberto, Sara J. Buhrlage, Sirano Dhe‐Paganon et al.|Cell chemical biology|2017Cited by 188
Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing CellsEllen Weisberg, James D. Griffin|PLoS ONE|2011Cited by 47
Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML CellsEllen Weisberg, Nathanael S. Gray|PLoS ONE|2013Cited by 42
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cellsEllen Weisberg, James D. Griffin|Blood|2008Cited by 31
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinaseEllen Weisberg, James D. Griffin|Oncotarget|2017Cited by 28